Beacon develops and commercializes point-of-care tests to help identify patients at a risk for having undiagnosed breast, colon-rectal and lung cancers.
Only investors on Gust who have been granted access can view this content.
Interested in this startup? Sign In or Sign Up to request more information.
Starting a startup?
Join the world's largest startup network for guidance, tools, and fundraising opportunities.
Get Started for Free